Tel.:
+34 91 736 2385
LOCAL TIME
Contact:
Katarina Gluic
Hours:
Mon-Thu 8:30-17:00 Fri 8:30-15:00
08:06
For help with a poster, please specify the poster number, the first author and the congress and we will reply shortly.
Poster no.
Contact name
E-mail
Telephone
Congress
Comments
53rd ERA-EDTA Congress
21-24 May 2016 Vienna
About us
FAQs
Help Line
Personal Area
Homepage
Discussion forum -
53rd ERA-EDTA Congress
Topic -
Clinical Nephrology, primary and secondary glomerulonephritis.
If you are already registered in PosterSessionOnline, enter your e-mail and click on LOGIN. Otherwise click on REGISTER
Thread / Poster
Author
Replies
Last reply
EFFECTIVENESS OF HIGH CUT-OFF HAEMODIALYSIS AND BORTEZOMIB BASED CHEMOTHERAPY IN ACUTE MYELOMA NEPHROPATHY
Fernando Pereira
1
5/11/2016 11:38:00 PM
IDIOPATHIC MINIMALCHANGE DISEASE IN ADULTS: LONG TERM RISK FACTORS FOR CHRONIC KIDNEY DISEASE
Lionel Carbillon
1
5/11/2016 11:30:00 PM
STEROID RESPONSIVENESS IN ADULT ONSET MINIMAL CHANGE NEPHROTIC SYNDROME
Lionel Carbillon
1
5/11/2016 11:28:00 PM
IDIOPATHIC MINIMAL CHANGE NEPHROTIC SYNDROME IN ADULTS: FREQUENCY AND PREDICTORS FACTORS OF RELAPSES
Lionel Carbillon
1
5/11/2016 11:26:00 PM
RITUXIMAB THERAPY FOR IDIOPATHIC NEPHROTIC SYNDROME
IARA DASILVA
1
5/11/2016 11:05:00 PM
ANCA ASSOCIATEDVASCULITIS: PROGNOSTIC STUDY
khadhar meriam
1
5/11/2016 3:28:00 PM
RHEUMATOID ARTHRITIS & KIDNEY DISEASE
khadhar meriam
1
5/11/2016 3:25:00 PM
CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH ANCA-ASSOCIATED VASCULITIS TREATED WITH PLASMA EXCHANGE IN A SINGLE CENTRE
Zdenka Hruskova
1
5/10/2016 3:22:00 PM
SUCCESSFUL TREATMENT OF SEVERE FOCAL SEGMENTAL GLOMERULOSCLEROSIS WITH COMBINED PLASMAPHERESIS AND TRIPLE IMMUNOSUPPRESSION
Liliana Cunha
1
5/9/2016 11:57:00 PM
GENETIC PREDISPOSITION TO ATYPICAL HAEMOLITIC URAEMIC SYNDROME: A SINGLE CENTER EXPERIENCE
Liliana Cunha
1
5/9/2016 11:52:00 PM
TWO SIDES OF THE SAME DISEASE: C3 GLOMERULONEPHRITIS
Fernando Pereira
1
5/9/2016 11:14:00 PM
RENAL INVOLVEMENT IN HCV RELATED CIRRHOSIS EVIDENCED AS GLOMERULAR AND TUBULAR DERANGEMENT
Anna Paola Mitterhofer
1
5/9/2016 11:02:00 PM
ANTI-PHOSPHOLIPASE A2 RECEPTOR AUTOANTIBODIES IN A GREEK POPULATION WITH IDIOPATHIC MEMBRANOUS NEPHROPATHY
Simella Provatopoulou
1
5/9/2016 10:33:00 PM
COCAINE-LEVAMISOLE INDUCED SYSTEMIC VASCULITIS: CASE REPORTS IN SOUTHERN BRAZIL
Vernica Antunes
1
5/9/2016 10:27:00 PM
TEN-YEAR FOLLOW-UP OF CYCLOSPORINE TREATED PATIENTS WITH IDIOPATHIC MEMBRANOUS NEPRHOPATHY; IS THERE STILL ANY BENEFIT?
Simella Provatopoulou
1
5/9/2016 10:25:00 PM
RANDALL-TYPE MIDD: THE DISEASE SPECTRUM
Florent Joly
1
5/9/2016 9:56:00 PM
VIMENTIN EXPRESSION AS A RISK FACTOR FOR LUPUS NEPHRITIS WORSENING
Katarzyna Jakuszko
1
5/9/2016 9:43:00 PM
TOCILIZUMAB TREATMENT FOR NEPHROTIC SYNDROME DUE TO SECONDARY AMYLOIDOSIS IN RHEUMATIC AND INFLAMMATORY DISEASES.
Sheila Cabello Pelegrín
1
5/9/2016 9:41:00 PM
IMPACT OF WARMING IN THE INCIDENCE OF LUPUS NEPHRITIS IN SOUTH OF TUNISIA
Azza Khedhiri
1
5/9/2016 9:37:00 PM
RITUXIMAB IN RESISTANT OR FREQUENT RELAPSER FOCAL SEGMENTAL GLOMERULOSCLEROSIS: NOT ALWAYS A SMASH RESULT
Raffaella Rizzo
1
5/9/2016 9:13:00 PM
REPEAT RENAL BIOPSY IMPROVES OXFORD CLASSIFICATION BASED PREDICTION OF IGA NEPHROPATHY OUTCOME
Perrine JULLIEN
1
5/9/2016 9:05:00 PM
ANTIGLYCAN IGG AUTOANTIBODY PREDICTS THE OXFORD CLASSIFICATION SCORES S AND T IN IGA NEPHROPATHY
nicolas maillard
1
5/9/2016 9:02:00 PM
COMPARATIVE TRANSCRIPTOME PROFILING OF THE SPLEEN AND KIDNEYS BY NEXT GENERATION SEQUENCING IN A LUPUS MURINE MODEL REVEALS NOVEL MOLECULAR PATHWAYS
ELENI FRANGOU
1
5/9/2016 8:12:00 PM
PREDICTIVE FACTORS FOR TREATMENT RESPONSE IN CRYOGLOBULINEMIC MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS ASSOCIATED WITH HCV INFECTION
Oana Obrisca
1
5/9/2016 7:34:00 PM
RITUXIMAB IS AN EFFECTIVE THERAPY FOR CALCINEURIN INHIBITOR RESISTANT/DEPENDENT OR INTOLERANT NEPHROTIC SYNDROME DUE TO IDIOPATHIC MINIMAL CHANGE DISEASE AND FOCAL SEGMENTAL GLOMERULOSCLEROSIS IN ADULTS
Indu Rao
1
5/9/2016 6:56:00 PM
THE EFFECT OF AQUAPORIN-2 ON THE EFFICACY OF TOLVAPTAN IN PATIENTS WITH NEPHROTIC SYNDROME
Eiichi Sato
1
5/9/2016 6:34:00 PM
RITUXIMAB IN CHALLENGING NEPHROTIC PATIENTS A CASE SERIES
Liliana Cunha
1
5/9/2016 6:05:00 PM
SYSTEMIC SMALL VESSEL VASCULITIS ASSOCIATED WITH ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES-OWN EXPERIENCE
Dorota Brodowska-Kania
1
5/9/2016 4:55:00 PM
FAMILY DEFECTS IN FACTOR H/FHRS OF THE COMPLEMENT IN IGA NEPHROPATHY.
Teresa Olea
1
5/9/2016 11:26:00 AM
CLINICAL MARKERS OF IGA NEPHROPATHY.
MichaL Florczak
1
5/9/2016 11:16:00 AM
EULAR/ERA-EDTA RECOMMENDATIONS FOR THE MANAGEMENT OF ANCA-ASSOCIATED VASCULITIS
David Jayne
1
5/9/2016 10:35:00 AM
TREATMENT OF IgA NEPHROPATHY WITH IMMUNOGLOBULINS
Jorge González Rodríguez
1
5/9/2016 10:03:00 AM
EPIDEMIOLOGY AND RISK FACTORS FOR CYTOMEGALOVIRUS INFECTIONS IN GLOMERULAR DISEASES TREATED WITH IMMUNOSUPPRESSIVE THERAPY
Yu Tzu
1
5/9/2016 2:41:00 AM
SERUM SUPAR DETERMINATIONS AS DIAGNOSTIC BIOMARKER OF FOCAL SEGMENTAL GLOMERULOSCLEROSIS - A RETROSPECTIVE ANALYSIS
Miguel Verdelho
1
5/9/2016 12:25:00 AM
RITUXIMAB TREATMENT IN RESISTANT PRIMARY GLOMERULONEPHRITIS: A CROATIAN CLINICAL RETROSPECTIVE STUDY
Mario Laganovi&263;
1
5/9/2016 12:06:00 AM
PAUCI IMMUNE RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS, CLINICAL AND HISTOPATHOLOGICAL DATA. EXPERIENCE FROM CROATIAN UNIVERSITY HOSPITAL
Matija Crnogorac
1
5/8/2016 10:44:00 PM
LUPUS NEPHRITIS: THE REALITY OF A PORTUGUESE NEPHROLOGY CENTRE
Catia Cunha
1
5/8/2016 9:26:00 PM
CD80 AND SUPAR - PROMISING BIOMARKERS OF PODOCYTOPATHIES?
Katarzyna Gniewek
1
5/8/2016 9:13:00 PM
OUTCOME AND IMMUNOSUPPRESSIVE TREATMENT OF ELDERLY PATIENTS WITH ANCA-ASSOCIATED VASCULITIS
Akiko Kato
1
5/8/2016 9:00:00 PM
LOW SERUM COMPLEMENT C3 LEVELS AT DIAGNOSIS OF ANCA-ASSOCIATED VASCULITIS IS ASSOCIATED WITH POOR RENAL PROGNOSIS
Jean-Franois Augusto
1
5/8/2016 8:29:00 PM
CHANGE IN GLOMERULAR FILTRATION RATE AND RENAL BIOMARKERS IN PATIENTS WITH CHRONIC KIDNEY DISEASE DUE TO ALPORT SYNDROME: INTERIM RESULTS FROM THE ATHENA STUDY, A PROSPECTIVELY DESIGNED NATURAL HISTORY STUDY
Michael Huang
1
5/8/2016 7:27:00 PM
GLOMERULAR DISEASE IN OBESE PATIENTS: NOT ALWAYS FSGS
Jennifer Lees
1
5/8/2016 6:43:00 PM
EVALUATION OF LUPUS NEPHRITIS REMISSION IN THE COHORT PATIENTS FROM ONE CENTER
Elena Zakharova V
1
5/8/2016 5:23:00 PM
THE CLINICAL SIGNIFICANCE OF PLA2R ANTIBODIES AND C3 DEPOSITION IN THE PROGRESSION OF MEMBRANOUS NEPHROPATHY
Ozan Yegit
1
5/8/2016 1:43:00 PM
EVALUATION OF IMMUNOREGULATORY EFFECTS OF HEAT SHOCK PROTEIN 70 IN PATIENTS WITH CHRONIC GLOMERULONEPHRITIS (CGN)
Natalia Neprintseva
1
5/8/2016 9:30:00 AM
PROGNOSIS IN PATIENTS WITH IGA NEPHROPATHY WITH EARLY LESION
Minami Mizutani
1
5/8/2016 7:28:00 AM
COMPENSATORY RECRUITMENT OF ENDOTHELIAL PROGENITOR CELLS IN LUPUS NEPHRITIS PATIENTS WITH PRESERVED RENAL FUNCTION
Ins Ferreira
1
5/8/2016 1:09:00 AM
CLINICOPATHOLOGICAL ANALYSIS OF IDIOPATHIC MEMBRANOUS NEPHROPATHY IN ADOLESCENTS:A MORE THAN TWO-YEAR RETROSPECTIVE STUDY FROM A SINGLE CHINESE NEPHROLOGY CENTER
Chao Li
1
5/7/2016 8:38:00 PM
EFFICACY OF COMBINATION THERAPY WITH CORTICOSTEROID AND CYCLOSPORINE AS REMISSION INDUCTION THERAPY FOR IDIOPATHIC MEMBRANOUS NEPHROPATHY WITH NEPHROTIC SYNDROME
Hiroaki Tanaka
1
5/7/2016 1:04:00 PM
URINARY NGAL AND RISK FOR PROGRESSION IN IGA NEPHROPATHY PATIENTS
DIMITRIS XIDAKIS
1
5/6/2016 4:22:00 PM
DOES HEMATURIA AT THE TIME OF RECURRENCE AFTER THE CLINICAL REMISSION OF IGA NEPHROPATHY INFLUENCE THE LONG-TERM RENAL PROGNOSIS ?
TAKAYUKI FUJII
1
5/6/2016 1:01:00 PM
ELEVATED SERUM IMMUNOGLOBULIN E LEVELS AS A MARKER FOR PROGRESSION OF IMMUNOGLOBULIN A NEPHROPATHY
Ji-Hoon Lee
1
5/6/2016 1:49:00 AM
GUT - KIDNEY AXIS IN THE PATHOGENESIS OF IGA NEPHROPATHY
Gabriella Lauriero
1
5/5/2016 2:07:00 PM
THE DISTURBANCE OF CARBOHYDRATE METABOLISM WITH PRIMARY AND SECONDARY GLOMERULONEPHRITIS DURING INTENSIVE THERAPY OF GLUCOCORTICOIDS
Guzel Nurullina
1
5/5/2016 10:39:00 AM
ANCA-NEGATIVE PAUCI-IMMUNE CRESCENTIC GLOMERULONEPHRITIS: CLINICAL AND HISTOLOGICAL FEATURES
JAVIER VILLACORTA
1
5/4/2016 5:14:00 PM
CLINICAL PROFILE OF NEPHROTIC SYNDROME IN ADULTS
Ravindra Prabhu Attur
1
5/4/2016 3:48:00 PM
THE EFFECT OF AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS
Lina Zaripova
1
5/4/2016 12:17:00 PM
ATYPICAL HEMOLYTIC-UREMIC SYNDROME IN PREGNANCY AND POSTPARTUM: COURSE AND OUTCOMES
Yulia Korotchaeva
1
5/4/2016 10:55:00 AM
CLINICAL OUTCOMES OF TONSILLECTOMY AND STEROID PULSE THERAPY FOR PATIENTS WITH IgA NEPHROPATHY
Atsushi Oyama
1
5/4/2016 3:43:00 AM
THE INFLUENCE OF RENIN-ANGIOTENSIN-ALDOSTERON SYSTEM (RAAS) BLOCKERS ON ASSMYMETRIC DIMETHYLARGININE (ADMA) LEVEL, PROTEINURIA AND KIDNEY AND HEART FUNCTION IN PATIENTS WITH GLOMERULONEPHRITIS
Heleniak
1
5/3/2016 12:30:00 PM
URINARY ALPHA 1 ACID GLYCOPROTEIN AS A BIOMARKER OF RENAL DISEASE ACTIVITY IN SYSTEMIC LUPUS ERYTHEMATOSUS
Ihab Ibrahim
1
5/2/2016 4:38:00 PM
VALIDATION OF HISTOPATHOLOGICAL CLASSIFICATION OF ANCA-ASSOCIATED RENAL VASCULITIS IN A MULTICENTER SPANISH COHORT STUDY
JAVIER VILLACORTA
1
5/2/2016 2:56:00 PM
PLASMA LEVELS OF THE SOLUBLE MER TYROSINE KINASE RECEPTOR ARE INDEPENDENTLY ASSOCIATED WITH PROTEINURIA IN LUPUS NEPHRITIS.
Marco Quaglia
1
4/30/2016 6:20:00 PM
COMPARISON OF THE EFFECT OF ORAL STEROID AND TONSILLECTOMY COMBINED WITH STEROID PULSE THERAPY FOR IGA NEPHROPATHY.
Yoshie Hoshino
1
4/27/2016 9:58:00 AM
THE ROLE OF B7.1 AND suPAR IN PODOCYTE INJURY AND FOCAL SEGMENTAL GLOMERULOSCLEROSIS
Flavio Vincenti
1
4/26/2016 9:17:00 PM
IGA NEPHROPATHY TREATMENT - IS INTRAVENOUS STEROID PULSES REGIMEN MORE EFFECTIVE IN RELAPSE PREVENTION THAN ORAL STEROIDS?
Ivo Laranjinha
1
4/25/2016 7:57:00 PM
IMPROVEMENT OF RENAL SURVIVAL WITH STEROID THERAPY IN IGA NEPHROPATHY WITH REDUCED GLOMERULAR FILTRATION RATIO.
Ivo Laranjinha
1
4/25/2016 7:43:00 PM
ANALYSIS OF CASES WITH FOCAL SEGMENTAL GLOMERULOSCLEROSIS: SINGLE CENTER EXPERIENCE
Yavuz Ayar
1
4/20/2016 10:28:00 AM
SHORT TERM EFFECTS OF PREDNISONE TREATMENT ON PROTEINURIA AND RENAL FUNCTION IN IGA NEPHROPATHY: RELATION WITH OXFORD CLASSIFICATION.
FRANCISCO JOSE BORREGO UTIEL
1
4/18/2016 9:16:00 PM
TREATING MEMBRANOUS NEPHROPATHY WITH LOW DOSES OF CYCLOPHOSPHAMIDE OR MYCOPHENOLATE: SIMILAR RESULTS IN EFFICACY AND LOW INCIDENCE OF ADVERSE EVENTS.
E. MERINO-GARCIA
1
4/18/2016 9:11:00 PM
Most viewed poster for this congress
Poster:
547
Visits:
1241
Title:
COMPARISON OF PATIENT HAEMOGLOBIN OUTCOMES WITH WEEKLY IRON ADMINISTRATION VS PER SESSION IRON ADMINISTRATION IN ADULT HAEMODIALYSIS PATIENTS
Authors:
Joao Fazendeiro , Ricardo Peralta, Carla Felix, Bruno Pinto, Ilidio Rodrigues, Carlos Oliveira, Anibal Ferreira, Pedro Ponce
Centre:
Fresenius Medical Care Portugal
Poster most viewed in this topic
Poster:
120
Visits:
28
Title:
CHANGE IN GLOMERULAR FILTRATION RATE AND RENAL BIOMARKERS IN PATIENTS WITH CHRONIC KIDNEY DISEASE DUE TO ALPORT SYNDROME: INTERIM RESULTS FROM THE ATHENA STUDY, A PROSPECTIVELY DESIGNED NATURAL HISTORY STUDY
Authors:
Michael Huang , Michelle Rheault, Oliver Gross, Gerald Appel, James Simon, Bertrand Knebelmann, Paul Grint, Jacqueline Blem, Ed Lombardi
Centre:
Regulus Therapeutics
About us
Terms and Conditions
Special Access
Commercial Web Access
Follow us on: